Cargando…
Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
Adrenal insufficiency (AI) is a life-threatening disorder, with increased morbidity and mortality, especially in case of an acute illness that can increase the requirement of cortisol. A novel infectious disease, termed Coronavirus Disease 2019 (COVID-19), appeared in 2020. Therefore, AI patients ar...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739913/ https://www.ncbi.nlm.nih.gov/pubmed/35002978 http://dx.doi.org/10.3389/fendo.2021.805647 |
_version_ | 1784629203103121408 |
---|---|
author | Sabbadin, Chiara Betterle, Corrado Scaroni, Carla Ceccato, Filippo |
author_facet | Sabbadin, Chiara Betterle, Corrado Scaroni, Carla Ceccato, Filippo |
author_sort | Sabbadin, Chiara |
collection | PubMed |
description | Adrenal insufficiency (AI) is a life-threatening disorder, with increased morbidity and mortality, especially in case of an acute illness that can increase the requirement of cortisol. A novel infectious disease, termed Coronavirus Disease 2019 (COVID-19), appeared in 2020. Therefore, AI patients are experiencing a novel challenge: the risk of infection. In our experience, a prompt contact to the Endocrine center (with a telemedicine consultation) and a full awareness of diseases (cortisol deficiency, COVID-19 and the self-management of an adrenal crisis) are important to motivate patients. Vaccine is an effective treatment to prevent hospitalization and aggressive course of COVID-19. Some patients manifest challenges due to inequitable access and vaccine hesitancy, resulting in a delay in the acceptance of vaccines despite the availability of vaccination services. Therefore, an effort of all physicians must be conducted in order to advise patients with AI. In this short review, we try to answer some frequently asked questions regarding the management of patients with AI. |
format | Online Article Text |
id | pubmed-8739913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87399132022-01-08 Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 Sabbadin, Chiara Betterle, Corrado Scaroni, Carla Ceccato, Filippo Front Endocrinol (Lausanne) Endocrinology Adrenal insufficiency (AI) is a life-threatening disorder, with increased morbidity and mortality, especially in case of an acute illness that can increase the requirement of cortisol. A novel infectious disease, termed Coronavirus Disease 2019 (COVID-19), appeared in 2020. Therefore, AI patients are experiencing a novel challenge: the risk of infection. In our experience, a prompt contact to the Endocrine center (with a telemedicine consultation) and a full awareness of diseases (cortisol deficiency, COVID-19 and the self-management of an adrenal crisis) are important to motivate patients. Vaccine is an effective treatment to prevent hospitalization and aggressive course of COVID-19. Some patients manifest challenges due to inequitable access and vaccine hesitancy, resulting in a delay in the acceptance of vaccines despite the availability of vaccination services. Therefore, an effort of all physicians must be conducted in order to advise patients with AI. In this short review, we try to answer some frequently asked questions regarding the management of patients with AI. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8739913/ /pubmed/35002978 http://dx.doi.org/10.3389/fendo.2021.805647 Text en Copyright © 2021 Sabbadin, Betterle, Scaroni and Ceccato https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Sabbadin, Chiara Betterle, Corrado Scaroni, Carla Ceccato, Filippo Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 |
title | Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 |
title_full | Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 |
title_fullStr | Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 |
title_full_unstemmed | Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 |
title_short | Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 |
title_sort | frequently asked questions in patients with adrenal insufficiency in the time of covid-19 |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739913/ https://www.ncbi.nlm.nih.gov/pubmed/35002978 http://dx.doi.org/10.3389/fendo.2021.805647 |
work_keys_str_mv | AT sabbadinchiara frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19 AT betterlecorrado frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19 AT scaronicarla frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19 AT ceccatofilippo frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19 |